Bioline Rx (YP2.STU) Q1 2026 Earnings

23MarConfirmed
Q1 2026
-0
-0
-0
-0

Details

Expected EPS
-0.0005528903999999999
Actual EPS
-0.00038753999999999997
Surprise EPS
0
Surprise Percent
+29.91%

Description

Bioline Rx (YP2.STU) has reported earnings of -0.00038753999999999997 per share for Q1 2026.

0 Comments

Share your thoughts